News
ELAN
22.52
-0.49%
-0.11
Elanco Secures USDA Approval For Befrena, Expands Dermatology Portfolio
NASDAQ · 3d ago
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 12/31/2025 21:05
Elanco gains approval of Befrena for canine dermatitis
Seeking Alpha · 12/31/2025 19:28
Elanco receives USDA approval for Befrena
TipRanks · 12/31/2025 19:05
Elanco Animal Health Gets Approval For Befrena From U.S. Department of Agriculture To Treat Canine Allergic And Atopic Dermatitis
Benzinga · 12/31/2025 19:02
Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis
PR Newswire · 12/31/2025 19:00
Weekly Report: what happened at ELAN last week (1222-1226)?
Weekly Report · 12/29/2025 09:47
Elanco (ELAN): Valuation Check After Credelio Quattro-CA1 Approval and Growing Wall Street Optimism
Simply Wall St · 12/24/2025 02:43
Regencell Bioscience is the top performing pharma stock YTD
Seeking Alpha · 12/23/2025 04:47
How New Pet Screwworm Treatment And Pipeline Moves At Elanco (ELAN) Have Changed Its Investment Story
Simply Wall St · 12/22/2025 17:19
Weekly Report: what happened at ELAN last week (1215-1219)?
Weekly Report · 12/22/2025 09:47
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 12/19/2025 12:50
Elanco CEO Bites Off More Shares of Fast-Rising Stock
Barron‘s · 12/19/2025 06:30
Elanco Animal Health Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 12/18/2025 17:56
Elanco Animal Health Price Target Raised to $22.00/Share From $18.00 by Morgan Stanley
Dow Jones · 12/18/2025 17:56
Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Raises Price Target to $22
Benzinga · 12/18/2025 17:46
Elanco Receives FDA Conditional Approval For Credelio Quattro CA1 To Treat Screwworm In Dogs
NASDAQ · 12/18/2025 14:09
Elanco’s Credelio Quattro tablets granted FDA conditional approval
TipRanks · 12/18/2025 13:51
Elanco Receives FDA Conditional Approval For Credelio Quattro-CA1, Expanding Treatment Options For New World Screwworm In Companion Animals
Benzinga · 12/18/2025 13:44
Jim Cramer Praises Elanco Animal Health: 'They've Turned That Company Around'
Benzinga · 12/18/2025 13:02
More
Webull provides a variety of real-time ELAN stock news. You can receive the latest news about Elanco Animal Health through multiple platforms. This information may help you make smarter investment decisions.
About ELAN
Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.